We are live on ! Find out more
COYA icon

Coya Therapeutics

7 hedge funds and large institutions have $4.37M invested in Coya Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding

Funds holding: 4 → 7 (+3)

0.2% less ownership

Funds ownership: 11.27% → 11.07% (-0.2%)

Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Sellers

No sellers this quarter

COYA Hedge Fund Activity: Q1 2023 in Review

7 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2023, worth a combined $4.37M — down 15% from $5.16M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new COYA positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $33.8K.

  • 7 institutional investors held Coya Therapeutics (COYA) as of Q1 2023, up from 4 in Q4 2022.
  • Funds reported $4.37M of Coya Therapeutics stock for Q1 2023, down 15% quarter-over-quarter.
  • 3 funds opened new Coya Therapeutics positions in Q1 2023 and 0 closed out, a net change of +3 holders.
  • The largest Coya Therapeutics buyer in Q1 2023 was BlackRock, an estimated $33.8K added.

Based on aggregated 13F filings for Q1 2023.